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and relieved at rest. Some patients suffer from pain at night.
OA pain is often episodic but may be constant in advanced
OA. Often there is a poor relationship between pain and joint
damage as assessed by X-ray, but some MRI studies revealed
that painful osteoarthritic joints show more MRI-abnormalities
such as synovial hypertrophy, synovial effusions and bone mar-
row edema lesions. Furthermore chronic inflammatory changes
can be present. Finally, self-reported pain is often influenced by
perceived helplessness, educational, social and psychological
factors showing the complexity of chronic pain. To approach the
pain problem it is necessary to study the principles of nociception
in the joint, the processing of nociceptive sensory input from the
joint in the central nervous system and the neuronal processes
in the thalamocortical system that generate the pain response
with its sensory and affective components.
Methods: In order to investigate pain mechanisms numerous
methods are being used including morphological methods to
visualize nerve fibres, electrophysiological methods to record
from nociceptive neurons in the peripheral and central nervous
system and approaches to assess pain behaviour. In humans
brain imaging techniques are widely used to show the activity in
the so-called thalamocortical pain matrix.
Results: Although osteoarthritis is a disease of cartilage it is
unlikely that pain arises from nociceptive stimulation of carti-
lage itself because cartilage does not seem to be innervated.
It is thought, therefore, that the pain is generated by nocicep-
tive stimulation of nerve fibres in capsule, menisci, ligaments
and subchondral bone. At these sites sensory endings of thin
myelinated A delta- and unmyelinated C-fibres have been visu-
alized. Electrophysiological recordings from nerve fibres in the
joint nerve have revealed the response properties of A-delta and
C-fibres to noxious stimuli. Nociceptive joint afferents are either
polymodal responding to noxious mechanical stimuli and to me-
diators such as inflammatory mediators or they are silent not
responding to mechanical stimulation under normal conditions.
Importantly, nociceptive nerve fibres can be sensitized during
pathological processes such as inflammation which results in
enhanced responsiveness of polymodal nociceptors to mechan-
ical stimulation (lowering of threshold, enhanced responses to
suprathreshold stimuli) and in the induction of mechanosensitivity
of silent nociceptors. Key to sensitization is the chemosensitiv-
ity of joint afferents. A-delta and C-fibres express receptors for
numerous mediators that play an important role in processes
of joint inflammation and osteoarthritis such as prostaglandins,
bradykinin, cytokines and others. Inflammatory mediators acti-
vate second messenger systems in neurons that influence ion
channels involved in stimulus transduction. Receptors in sensory
nerve fibres can be upregulated under acute and chronic painful
conditions. This process of peripheral sensitization can induce
a state of central sensitization. An important amplification of the
nociceptive processing through the process of central sensiti-
zation takes place in the spinal cord. Data from OA patients
indicate that central sensitization is present in painful OA states.
Ascending tracts convey the information from the spinal cord to
the thalamocortical system where the conscious pain response
is generated. Imaging data emphasize the existence of two sys-
tems that are involved in pain. The lateral thalamocortical system
consisting of lateral thalamic relay nuclei and the cortical areas
S1 and S2 produces the sensory discriminative pain response
analysing the site, intensity and duration of painful stimuli. The
medial thalamocortical system consisting of medial thalamic nu-
clei and cortical areas in the insula, the anterior cingulate gyrus
and the prefrontal cortex produces the affective pain response
which causes the suffering from pain.
Conclusions: OA pain under activated conditions such as acute
episodes of inflammation or chronic inflammatory conditions is
likely to result from peripheral and central sensitization. Whether
additional mechanisms such as damage of nerve fibres and
elements of neuropathic pain contribute to OA pain is being
explored. Future progress in the understanding of OA pain is
expected from techniques that allow to correlate pathological
changes in the diverse joint structures with the experience of
pain and from the work on experimental models that are relevant
for human OA.
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NEW METHODS FOR MOLECULAR DISCOVERY IN
OSTEOARTHRITIS: A FOCUS ON CELL SIGNALING
Richard F. Loeser Jr.
A better understanding of basic molecular mechanisms that reg-
ulate cartilage matrix destruction is needed in order to develop
new treatments for osteoarthritis that have the potential to slow
disease progression. It is well accepted that the chondrocyte is
responsible for the progressive destruction and loss of its own
matrix through the release of degradative enzymes accompa-
nied by an inadequate repair response. This appears to result
from an imbalance in chondrocyte anabolic and catabolic activity.
Studies on the cell signaling pathways in chondrocytes that regu-
late anabolic and catabolic activity, including the effects of aging
on these pathways, should define novel targets for correcting
the imbalance. Genomics approaches have defined numerous
genes that are up or downregulated in OA chondrocytes when
compared to chondrocytes from normal joints. Expression of
many of these genes may be regulated by a common set of
key signaling intermediates that are activated in response to
stimulation of chondrocytes by cytokines and by signals from
the matrix mediated by the integrin family of receptors. Phos-
phorylation of specific tyrosine, serine and threonine residues
mediated by kinases is a common mechanism for propagation of
intracellular signals. Recently, the role of reactive oxygen species
(ROS) as secondary messengers in cell signaling has become
better understood. The reversible oxidation of specific cysteine
residues to cysteine sulfenic acid acts to regulate the activity of
many signaling proteins including kinases and phosphatases. In
this workshop, cell signaling pathways relevant to the regulation
of chondrocyte anabolic and catabolic activity will be reviewed
with a focus on the methodologies used to study signal trans-
duction. Advantages and pitfalls of various methodologies will be
discussed with the goal of facilitating an interactive discussion
on new methods that can be used to better understand basic
molecular mechanisms regulating chondrocyte function.
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MRI IN OSTEOARTHRITIS, USEFUL FOR THE
RESEARCHER AND CLINICIAN
Philip G. Conaghan
Magnetic resonance imaging (MRI) provides unparalleled ability
to visualise all the structures involved in the whole-organ joint
failure process that is osteoarthritis (OA). For the researcher it
provides a new level of in vivo understanding of the key tissue
pathology. The majority of MRI OA studies to date have focussed
on the knee joint. Large cohort studies have demonstrated fre-
quent abnormalities of cartilage, menisci, bone (bone marrow
lesions, BML, and osteophytes), even when there is minimal
radiographic abnormalities.
An important basic requirement for the researcher is valid meth-
ods of quantifying this joint pathology. Quantitative measures of
cartilage and semi-quantitative score systems for all the knee
structural features have been developed, and increasing data
on their validity, reliability and sensitivity to change have been
published over the last few years.
The next step is to understand the importance of these MRI
S12 Abstracts from Invited Speakers
abnormalities and their role in the natural history of OA. This work
is also evolving. The key intra-articular structures associated with
knee pain appear to be BML and synovitis. Cartilage loss has
also been weakly associated with knee pain, perhaps through
associations with other tissue abnormalities. In terms of structural
joint deterioration, large cohorts have evaluated rates of cartilage
loss at the knee and the predictive factors for this; certainly
weight-bearing portions have been demonstrated to have more
rapid progression of cartilage loss. The importance of meniscal
degeneration and extrusion in progressive cartilage loss has also
been demonstrated. BML have been associated with high rates of
radiographic OA progression in the ipsilateral knee compartment.
The progressive advances in MRI hardware and software mean
not only better definition of pathology and clearer quantification
of, for example, cartilage, but also improved ability to under-
standing functional response of tissue in vivo, for example, by
looking at proteoglycan loss in cartilage using techniques such
as dGEMRIC.
For clinicians, MRI has brought understanding but as yet little
help. Understanding of the crucial early pathology of menisci or
hyaline cartilage may soon change when we consider applying
the label of OA, and allow us to define ‘early’ OA. A study
demonstrating peri-articular causes of knee pain (eg anserine
bursitis) highlights the continued importance of adequate clinical
assessment. Certainly MRI allows us to define OA subsets, but
there are very limited data on how this information can currently
help clinicians; this will certainly change over the next few years.
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DESTRUCTIVE AND NON-DESTRUCTIVE
AGGRECANOLYSIS IN HUMAN OSTEOARTHRITIS
John Sandy
Our understanding of aggrecanolysis in the human knee joint
has recently been clarified by detailed biochemical analysis of
naturally occurring aggrecan products [1] and confocal imaging
of the human aggrecanases (ADAMTS 1, 4, 5, 8, 9, 15) [2]. In this
presentation, data will be described which shows that ADAMTS5
is unique among the aggrecanases in that it forms complexes
with hyaluronan in cartilage of murine OA models and in both
human post-injury and late-stage human OA cartilages. This find-
ing,which has been established with both fluorescence colocal-
ization imaging and biochemical analysis of extracts, along with
the marked increases in ADAMTS5 protein abundance in human
OA cartilages, indicate that ADAMTS5 is primarily responsible
for destructive aggrecanolysis at Glu392-Ala393 (to generate
G1-NITEGE) in human joint disease. In contrast, one or more
MMPs appears to be responsible for non-destructive cleavage
of aggrecan at Asn360-Phe361 to generate G1-VDIPEN360.
These findings, along with recent studies in MMP-9-null and
ADAMTS-5 null mice, suggest that ADAMTS5-mediated aggre-
canolysis is destructive to murine and human cartilage function,
whereas MMP-mediated aggrecanolysis is non-destructive. In-
stead, MMP-mediated aggrecanolysis may be required to main-
tain normal aggrecan composition and organization [3].
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PAIN SEVERITY SCORING SYSTEM IN OSTEOARTHRITIS
(OA)
Gillian Hawker
Objectives: Despite the importance of pain in OA, little is known
about the quality and characteristics of OA pain, or how these
change over time as the disease progresses. An international
OMERACT/OARSI working group was created in 2004 to develop
pain, physical function and structure states that represent the
progression from early to late disease for individuals with hip and
knee OA. The objective of the pain group was to examine the
pain experience of people with hip/knee OA from early to late
disease to inform the development of a new pain measure for
OA.
Methods: A two-part study, comprised of focus groups and
completion of a standardized questionnaire, was performed in
individuals with a range of levels of pain severity and duration
of hip and/or knee OA symptoms, across 6 centers. English-
speaking men and women with OA aged 40+ years and who
experienced pain on most days of at least one month in the past
year were invited to participate. Focus group methods were stan-
dardized and conducted separately in people with mild, moderate
and severe pain, in men and women, and in individuals with hip
versus knee OA. Each focus group, comprised of up to 8 partici-
pants, used a "funnel approach" starting with broad open-ended
questions regarding the characteristics of the hip/knee symp-
toms over time, and then increasingly focused on more specific
issues, including those aspects of the symptoms they found most
distressing. Focus groups were audio taped and transcribed ver-
batim into Microsoft Word. Content analysis was performed to
identify distinct themes. A modification of Ruta et al’s Patient
Generated Index (PGI) was used to assess the priorities and
concerns of individuals living with hip or knee OA pain, and the
varying weights and values that they attach to their concerns.
The PGI is comprised of 3 parts: Part 1 - participants identified
aspects of their OA pain/symptoms that they considered most
distressing. Part 2 - participants were asked to rate how far they
were from their ideal in each of the chosen areas on a 7-point
Likert scale. Part 3 - participants weighed the relative importance
of the different areas for their overall quality of life. Content anal-
ysis was performed to identify consistent responses and trends
over time (from early to late disease) in the pain/symptom ele-
ments identified as most distressing. Using both focus group and
PGI derived data an OA pain/symptom severity scoring system
was developed and evaluated in existing cohorts of people with
hip/knee OA for reliability and validity against existing OA pain
measures.
Results: Preliminary results suggest there are no clear pat-
terns of change in symptoms over time. Hip symptoms appear
to progress more rapidly than do knee symptoms, and are
described as more distressing. Night pain was described in in-
dividuals with only a short duration of symptoms as often as
for those with long-standing complaints, but worsened with in-
creased duration of disease. Two types of pain were evident - a
background ache or discomfort that was present most of the time
and a more intense but short lived pain which limited activities.
Final results from focus groups and interviews will be presented,
together with results from evaluation of the new pain/symptom
OA measure.
